DK0861892T3 - Stressproteinepitoper - Google Patents

Stressproteinepitoper

Info

Publication number
DK0861892T3
DK0861892T3 DK98102990T DK98102990T DK0861892T3 DK 0861892 T3 DK0861892 T3 DK 0861892T3 DK 98102990 T DK98102990 T DK 98102990T DK 98102990 T DK98102990 T DK 98102990T DK 0861892 T3 DK0861892 T3 DK 0861892T3
Authority
DK
Denmark
Prior art keywords
purified
epitope
stress protein
synthesised
substitution
Prior art date
Application number
DK98102990T
Other languages
English (en)
Inventor
James Peter Burnie
Ruth Christine Matthews
Original Assignee
Neutec Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Plc filed Critical Neutec Pharma Plc
Application granted granted Critical
Publication of DK0861892T3 publication Critical patent/DK0861892T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK98102990T 1992-08-18 1993-08-17 Stressproteinepitoper DK0861892T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9217542A GB2270076A (en) 1992-08-18 1992-08-18 Human HSP 90 Epitopes
EP93918042A EP0656945B1 (en) 1992-08-18 1993-08-17 Stress protein epitopes

Publications (1)

Publication Number Publication Date
DK0861892T3 true DK0861892T3 (da) 2005-02-14

Family

ID=10720544

Family Applications (2)

Application Number Title Priority Date Filing Date
DK93918042T DK0656945T3 (da) 1992-08-18 1993-08-17 Stressproteinepitoper
DK98102990T DK0861892T3 (da) 1992-08-18 1993-08-17 Stressproteinepitoper

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK93918042T DK0656945T3 (da) 1992-08-18 1993-08-17 Stressproteinepitoper

Country Status (12)

Country Link
US (1) US5777083A (da)
EP (2) EP0861892B1 (da)
JP (1) JP3439213B2 (da)
AT (2) ATE192192T1 (da)
AU (1) AU4727593A (da)
DE (2) DE69333673T2 (da)
DK (2) DK0656945T3 (da)
ES (2) ES2231907T3 (da)
GB (1) GB2270076A (da)
GR (1) GR3033809T3 (da)
PT (2) PT656945E (da)
WO (1) WO1994004676A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750119A (en) 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US5997873A (en) 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
US5985270A (en) * 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US5935576A (en) * 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US5837251A (en) * 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
CA2242911A1 (en) * 1996-01-16 1997-07-24 Kay C. Dee Peptides for altering osteoblast adhesion
US6017540A (en) 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US5830464A (en) 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
GB9710762D0 (en) * 1997-05-23 1997-07-23 Cancer Res Inst Royal Binding complexes
US5948646A (en) 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
EP1054683B1 (en) 1998-02-20 2007-04-11 University Of Miami Modified heat shock protein-antigenic peptide complex
GB0008305D0 (en) * 2000-04-06 2000-05-24 Neutec Pharma Plc Treatment of fungal infections
AU6669401A (en) 2000-06-02 2001-12-11 Univ Connecticut Health Ct Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
US7622446B2 (en) * 2001-04-18 2009-11-24 The Open University Polypeptides, derivatives and uses thereof
US7491702B2 (en) 2001-04-18 2009-02-17 The Open University Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same
US6916626B1 (en) * 2001-04-25 2005-07-12 Rockeby Biomed Ltd. Detection of Candida
US7666581B2 (en) 2001-08-20 2010-02-23 University Of Connecticut Health Center Methods for preparing compositions comprising heat shock proteins useful for the treatment of cancer and infectious disease
DE10161051B4 (de) * 2001-12-12 2005-09-15 Wieland, Heinrich, Prof. Dr. Diagnose der Malaria
US7959915B2 (en) 2003-03-12 2011-06-14 Tufts University Inhibitors of extracellular Hsp90
US7807378B2 (en) * 2005-12-29 2010-10-05 Industrial Technology Research Institute (Itri) Method of diagnosing myasthenia gravis and kits therefor
ATE509271T1 (de) * 2006-01-04 2011-05-15 Ind Tech Res Inst Verfahren zur diagnose von myasthenia gravis
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット
WO2007098229A2 (en) * 2006-02-21 2007-08-30 Michigan State University Geldanamycin derivatives and method of use thereof
US20100113355A1 (en) 2007-04-27 2010-05-06 Naresh Chennamsetty Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
DK2257301T3 (da) 2008-03-03 2014-04-28 Univ Miami Immunterapi baseret på allogene cancerceller.
KR20110017356A (ko) 2008-03-20 2011-02-21 유니버시티 오브 마이애미 열충격 단백질 ｇｐ96 백신접종 및 이를 사용하는 방법
PT2424889E (pt) 2009-04-30 2015-11-12 Ablynx Nv Método de produção de anticorpos de domínio
ES2845727T3 (es) 2015-02-06 2021-07-27 Heat Biologics Inc Vector que coexpresa una vacuna y moléculas coestimuladoras
US11666649B2 (en) 2016-10-11 2023-06-06 University Of Miami Vectors and vaccine cells for immunity against Zika virus
US11548930B2 (en) 2017-04-04 2023-01-10 Heat Biologics, Inc. Intratumoral vaccination

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8915019D0 (en) * 1989-06-30 1989-08-23 Matthews Ruth C Medicaments
US5188964A (en) * 1990-04-12 1993-02-23 Board Of Regents, The University Of Texas System Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
GB9016315D0 (en) * 1990-07-25 1990-09-12 Burnie James P Medicaments
DE4201181A1 (de) * 1992-01-17 1993-07-22 Boehringer Mannheim Gmbh Verfahren zur stabilisierung von proteinen

Also Published As

Publication number Publication date
ES2231907T3 (es) 2005-05-16
DE69333673T2 (de) 2006-03-09
DE69328489D1 (de) 2000-05-31
JP3439213B2 (ja) 2003-08-25
EP0656945B1 (en) 2000-04-26
US5777083A (en) 1998-07-07
EP0861892A1 (en) 1998-09-02
EP0656945A1 (en) 1995-06-14
EP0861892B1 (en) 2004-10-20
JPH08500016A (ja) 1996-01-09
AU4727593A (en) 1994-03-15
PT656945E (pt) 2000-08-31
GR3033809T3 (en) 2000-10-31
WO1994004676A1 (en) 1994-03-03
ATE192192T1 (de) 2000-05-15
DK0656945T3 (da) 2000-09-11
DE69328489T2 (de) 2000-11-30
PT861892E (pt) 2005-03-31
GB9217542D0 (en) 1992-09-30
ATE280227T1 (de) 2004-11-15
GB2270076A (en) 1994-03-02
ES2147560T3 (es) 2000-09-16
DE69333673D1 (de) 2004-11-25

Similar Documents

Publication Publication Date Title
DK0861892T3 (da) Stressproteinepitoper
PT725824E (pt) Epitopos de celulas t humanas imunodominantes do virus da hepatite c
DE69627704T2 (de) Protegrine
KR900700469A (ko) 우레탄-보호된 아미노산-n-카르복시무수물
ATE178907T1 (de) Rezeptorbindende region des diphtherietoxius
ES2087323T3 (es) Metodo para producir peptidos exentos de cisteina.
PT711305E (pt) Protegrinas
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
NL300271I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
ATE166359T1 (de) Peptide mit einer lanthionin-brücke
CA2137280A1 (fr) Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications
YU48525B (sh) Protein, dnk koji kodira protein, rekombinantni vektor koji obuhvata dnk i postupak za proizovodnju proteina
AU3172193A (en) Novel megakaryocyte amplifier
DE69331368D1 (de) Herstellung und Benützung eines Metastasehemmendes Proteines.
DK0504335T3 (da) Fibronectinbindende peptid
DE59102761D1 (de) Neue promotorregion.
ES2097368T3 (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.
ATE216706T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
HUP9900498A2 (hu) Új, helicobacter pylori membrán fehérjék
PT959895E (pt) Peptidos que reajem a anticorpos contra um peptido de consenso da familia de proteinas cs4-cfa/i